Argo Biopharma Shares Phase II Results for BW-20805 at AAAAI
-Poster Presentation Selected as Late Breaking Abstract- Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage small interfering RNA (siRNA) therapeutics company, has been selected as...